Long-Term, Observational, Global Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies

drug protocol number
ALXN-MG-50
drug sponsor
AstraZeneca/ IQVIA
drug study
Eculizumab
drug trial site
Aseer Hospital (Abha)
drug status
Ongoing
drug phase